EUVIMEDOpdag EUVIMED
Crossref

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Mallory R Taylor iD, James R Anderson, Julie R Park, Meredith S Irwin iD, Mark A Applebaum iD, Navin R Pinto, Keri Streby iD, Sara M Federico, Carolina Rosswog, Miki Ohira iD, Pei-Chi Kao, Wendy B London iD and 1 more

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31968 ↗

At a glance

Journal article in Pediatric Blood & Cancer, 2025. Written by Mallory R Taylor and 12 co-authors. Institution: Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Neuroblastoma, N-Myc Proto-Oncogene Protein. Cited 3 times so far (Crossref); 23 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background Toddlers (age 365–

Subjects

MeSH terms (MEDLINE)

NeuroblastomaN-Myc Proto-Oncogene ProteinHumansInfantMaleFemalePrognosisSurvival RateFollow-Up StudiesGene Amplification

Author keywords

international databaseneuroblastomaoutcomes

Substances

N-Myc Proto-Oncogene ProteinMYCN protein, human

Authors and institutions

  • Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.
  • Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.

ORCID profiles: Mallory R Taylor, Meredith S Irwin, Mark A Applebaum, Keri Streby, Miki Ohira, Wendy B London

Cite

APA

Taylor, M. R., Anderson, J. R., Park, J. R., Irwin, M. S., Applebaum, M. A., Pinto, N. R., Streby, K., Federico, S. M., Rosswog, C., Ohira, M., Kao, P. C., London, W. B., & Cash, T. (2025). Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31968

Vancouver

Taylor MR, Anderson JR, Park JR, Irwin MS, Applebaum MA, Pinto NR, et al. Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31968

BibTeX
@article{Taylor2025,
  author = {Taylor, Mallory R and Anderson, James R and Park, Julie R and Irwin, Meredith S and Applebaum, Mark A and Pinto, Navin R and Streby, Keri and Federico, Sara M and Rosswog, Carolina and Ohira, Miki and Kao, Pei-Chi and London, Wendy B and Cash, Thomas},
  title = {Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31968}
}
Start for free →